Matty Sey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Matty Sey has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Andres Rodriguez
Department of Biomedical Engineering, Florida International University, Miami, FL 33174, USA
1 shared publication - Arvind Agarwal
Florida International University
1 shared publication - Asad Mirza
Department of Biomedical Engineering, Florida International University, Miami, FL, 33199, United States
1 shared publication - Chia-Pei Denise Hsu
Department of Biomedical Engineering, Florida International University, Miami, FL 33174, USA
1 shared publication - Joshua D. Hutcheson
Department of Biomedical Engineering, Florida International University
1 shared publication - Lihua Lou
Clemson University
1 shared publication
Latest Publications
- Open Access
- 24 September 2024
- Published by MDPI AG in Bioengineering
- Vol. 11 (10) , 955
Computational Model for Early-Stage Aortic Valve Calcification Shows Hemodynamic Biomarkers
Heart disease is a leading cause of mortality, with calcific aortic valve disease (CAVD) being the most prevalent subset. Being able to predict this disease in its early stages is important for monitoring patients before they need aortic valve replacement surgery. Thus, this study explored hydrodynamic, mechanical, and hemodynamic differences in healthy and very mildly calcified porcine small intestinal submucosa (PSIS) bioscaffold valves to determine any notable parameters between groups that could, possibly, be used for disease tracking purposes. Three valve groups were tested: raw PSIS as a control and two calcified groups that were seeded with human valvular interstitial and endothelial cells (VICs/VECs) and cultivated in calcifying media. These two calcified groups were cultured in either static or bioreactor-induced oscillatory flow conditions. Hydrodynamic assessments showed metrics were below thresholds associated for even mild calcification. Young’s modulus, however, was significantly higher in calcified valves when compared to raw PSIS, indicating the morphological changes to the tissue structure. Fluid–structure interaction (FSI) simulations agreed well with hydrodynamic results and, most notably, showed a significant increase in time-averaged wall shear stress (TAWSS) between raw and calcified groups. We conclude that tracking hemodynamics may be a viable biomarker for early-stage CAVD tracking.
- 24 September 2024
- Published by MDPI AG in Bioengineering
- Vol. 11 (10) , 955
Open AccessComputational Model for Early-Stage Aortic Valve Calcification Shows Hemodynamic Biomarkers
Heart disease is a leading cause of mortality, with calcific aortic valve disease (CAVD) being the most prevalent subset. Being able to predict this disease in its early stages is important for monitoring patients before they need aortic valve replacement surgery. Thus, this study explored hydrodynamic, mechanical, and hemodynamic differences in healthy and very mildly calcified porcine small intestinal submucosa (PSIS) bioscaffold valves to determine any notable parameters between groups that could, possibly, be used for disease tracking purposes. Three valve groups were tested: raw PSIS as a control and two calcified groups that were seeded with human valvular interstitial and endothelial cells (VICs/VECs) and cultivated in calcifying media. These two calcified groups were cultured in either static or bioreactor-induced oscillatory flow conditions. Hydrodynamic assessments showed metrics were below thresholds associated for even mild calcification. Young’s modulus, however, was significantly higher in calcified valves when compared to raw PSIS, indicating the morphological changes to the tissue structure. Fluid–structure interaction (FSI) simulations agreed well with hydrodynamic results and, most notably, showed a significant increase in time-averaged wall shear stress (TAWSS) between raw and calcified groups. We conclude that tracking hemodynamics may be a viable biomarker for early-stage CAVD tracking.